Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

389
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
389
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

459
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
459
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

633
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
633
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

212
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial DNA-mediated cGAS-STING activation and its crosstalk with NLRP3 inflammasome in chronic obstructive pulmonary disease.

Cytokine & growth factor reviews·2026
Same author

The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis.

Pharmacogenomics·2026
Same author

Overcoming tumour resistance in cancer immunotherapy through predictive and pharmacodynamic biomarkers.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2025
Same author

Relationship between polymorphisms in the TGF-β receptor gene and susceptibility towards chronic obstructive pulmonary disease in Northern Indians.

Expert review of respiratory medicine·2025
Same author

Molecular insights into TGF-B signalling pathway disruption by non-synonymous SNPs variants in COPD: an <i>in silico</i> and molecular dynamics simulation study.

Journal of biomolecular structure & dynamics·2025
Same author

Seroprevalence of IgG antibodies against hepatitis-A infection among individuals aged 6-30 years in India, 2021: a nationwide population-based cross-sectional study.

The Lancet regional health. Southeast Asia·2025

Related Experiment Video

Updated: Sep 19, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Tuberculosis and co-morbidities: Multidisciplinary care model.

Vishal Chopra1, Kranti Garg2

  • 1Department of Pulmonary Medicine, Government Medical College, Patiala, Punjab, India; State TB Training and Demonstration Centre, Patiala, Punjab, India.

The Indian Journal of Tuberculosis
|June 15, 2025
PubMed
Summary
This summary is machine-generated.

Recognizing and treating co-morbidities like HIV and diabetes in Tuberculosis patients improves outcomes. Multidisciplinary clinics are needed for comprehensive, cost-effective TB care.

Keywords:
Co-morbidityMultidisciplinary careTuberculosis

More Related Videos

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.0K
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

12.0K

Related Experiment Videos

Last Updated: Sep 19, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.0K
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

12.0K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Growing recognition of co-morbidities significantly impacts Tuberculosis (TB) treatment outcomes.
  • The National TB Elimination Program (NTEP) prioritizes Human Immunodeficiency Virus (HIV) and Diabetes Mellitus (DM) management alongside TB.
  • Numerous other undiagnosed and untreated co-morbidities are associated with TB, complicating patient care.

Purpose of the Study:

  • To highlight the critical need for integrated care models for Tuberculosis patients with co-morbidities.
  • To advocate for the establishment of multidisciplinary clinics for comprehensive TB management.
  • To improve overall patient outcomes and reduce morbidity and mortality associated with complex TB cases.

Main Methods:

  • Review of current awareness and program emphasis on TB co-morbidity management.
  • Analysis of the impact of co-morbidities on TB treatment efficacy.
  • Conceptual proposal for multidisciplinary care clinics within medical colleges.

Main Results:

  • Current programs focus on key co-morbidities (HIV, DM) but overlook others.
  • Untreated co-morbidities are linked to poorer TB treatment results.
  • Integrated care can enhance patient management, save time, and reduce costs.

Conclusions:

  • Multidisciplinary clinics are essential for holistic TB patient management.
  • Such integrated care models can lead to better treatment outcomes and reduced mortality.
  • Further research and recommendations are needed for effective co-morbidity management in TB.